VZV gH Antibodies

Santa Cruz Biotechnology offers a broad range of VZV gH monoclonal antibodies for research applications. VZV gH Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The glycoprotein gH of Varicella-Zoster Virus (VZV) plays a crucial role in viral entry and fusion, making it essential for understanding the mechanisms of VZV pathogenesis and immune evasion. Given its importance in the lifecycle of the virus, VZV gH is a significant target for therapeutic interventions and vaccine development. Research on VZV gH can provide insights into the virus's behavior and its interactions with host cells. VZV gH studies have revealed important aspects of viral membrane fusion and cell-to-cell spread. Understanding VZV gH function has implications for developing new antiviral strategies and improving existing vaccines. The molecular characterization of VZV gH continues to expand our knowledge of viral entry mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of VZV-related diseases and potential therapeutic approaches.